Ch05: Red and White Lesions of the Oral Mucosa

More documents

Recommendations

Info

122 Diagnosis and Management of Oral and Salivary Gland Diseases 153. Silverman S Jr. Diagnosis and management of leukoplakia and premalignant lesions. Atlas Oral Maxillofac Surg Clin North Am 1998;10:13–23. 154. Al-Drouby HA. Oral leukoplakia and cryotherapy. Br Dent J 1983;155(4):124–5. 155. Horch HH, Gerlach KL, Schaefer HE. CO2 laser surgery of oral premalignant lesions. Int J Oral Maxillofac Surg 1986;15(1):19–24. 156. Kaugars GE, Silverman S Jr, Lovas JL, et al. A review of the use of antioxident supplements in the treatment of human oral leukoplakia. Oral Surg Oral Med Oral Pathol 1996;81:5–14. 157. Krebs-Smith SM. Progress in improving diet to reduce cancer risk. Cancer 1998;83:1425–32. 158. Enwonwu CO, Meeks VI. Bionutrition and oral cancer in humans. Crit Rev Oral Biol Med 1995;6(1):5–17. 159. Pindborg JJ, Daftary DK, Mehta FS. A follow-up study of sixtyone oral dysplastic precancerous lesions in Indian villagers. Oral Surg Oral Med Oral Pathol 1977;43(3):383–90. 160. Schepman KP, van der Meij EH, Smeele LE, van der Waal I. Concomitant leukoplakia in patients with oral squamous cell carcinoma. Oral Dis 1999;5:206–9. 161. Gorlin RJ. Bowen’s disease of the mucous membrane of the mouth. A review of the literature and a presentation of six cases. Oral Surg Oral Med Oral Pathol 1950;3:35. 162. Daley T, Birek C, Wysocki GP. Oral bowenoid lesions: differential diagnosis and pathogenetic insights. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2000;90(4):466–73. 163. Kratochvil FJ, Cioffi GA, Auclair PL, Rathburn WA. Virusassociated dysplasia (bowenoid papulosis?) of the oral cavity. Oral Surg Oral Med Oral Pathol 1989;68:312. 164. Brightman VJ. Red and white lesions of the oral mucosa. In: Lynch MA, Brightman VJ, Greenberg MS, editors. Burket’s oral medicine. 9th ed. Philadelphia: J.B. Lippincott; 1997. 165. Crissman JD, Visscher DW, Sakr W. Premalignant lesions of the upper aerodigestive tract: pathologic classification. J Cell Biochem Suppl 1993;17F:49–56. 166. Hashibe M, Mathew B, Kuruvilla B, et al. Chewing tobacco, alcohol, and the risk of erythroplakia. Cancer Epidemiol Biomarkers Prev 2000;9(7):639–45. 167. Kramer IR, Lucas RB, Pindborg JJ, Sobin LH. Definition of leukoplakia and related lesions: an aid to studies on oral precancer. Oral Surg Oral Med Oral Pathol 1978;46(4):518–39. 168. Mashberg A, Garfinkel L. Early diagnosis of oral cancer: the erythroplastic lesion in high risk sites. CA Cancer J Clin 1978;28(5):297–303. 169. Mashberg A, Samit A. Early diagnosis of asymptomatic oral and oropharyngeal squamous cancers. CA Cancer J Clin 1995;45(6):328–51. 170. Seoane J, Varela-Centelles PI, Diz Dios P, et al. Experimental intervention study about recognition of erythroplakia by undergraduate dental students. Int Dent J 1999;49(5):275–8. 171. Shafer WG, Waldron CA. Erythroplakia of the oral cavity. Cancer 1975;36(3):1021–8. 172. Shear M. Erythroplakia of the mouth. Int Dent J 1972;22(4):460–73. 173. Zegarelli DJ, Sabbagh E. Relative incidence of intraoral pemphigus vulgaris, mucous membrane pemphigoid and lichen planus. Ann Dent 1989;48(1):5–7. 174. Black MM. Lichen planus and lichenoid eruptions. In: Rook A, Wilkinson DS, Ebling FJG, et al, editors. Textbook of dermatology. 4th ed, Boston: Blackwell; 1986. 175. Conklin RJ, Blasberg B. Oral lichen planus. Dermatol Clin 1987;5(4):663–73. 176. Scully C, El-Kom M. Lichen planus: review and update on pathogenesis. J Oral Pathol 1985;14(6):431–58. 177. Porter SR, Kirby A, Olsen I, et al. Immunologic aspects of dermal and oral lichen planus. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1997;83:858–63. 178. Vincent SD, Fotos PG, Baker KA, et al. Oral lichen planus: the clinical, historical and therapeutic features of 100 cases. Oral Surg Oral Med Oral Pathol 1990;70:165–71. 179. Silverman S Jr, Gorsky M, Lozada-Nur F, Gionnotti K. A prospective study of findings and management in 214 patients with oral lichen planus. Oral Surg Oral Med Oral Pathol 1991;72:665–70. 180. McClatchy KD, Silverman S Jr, Hansen LS. Studies on oral lichen planus III: clinical and histologic correlations in 213 patients. Oral Surg Oral Med Oral Pathol 1975;39:122–7. 181. Thorn JJ, Holmstrup P, Rindum J, Pindborg JJ. Course of various clinical forms of oral lichen planus: a prospective followup study of 611 patients. J Oral Pathol 1988;17(5):213–8. 182. Allen CM, Beck FM, Rossie KM, Kaul TJ. Relation of stress and anxiety to oral lichen planus. Oral Surg Oral Med Oral Pathol 1986;61(1):44–6. 183. Yiannias JA, el-Azhary RA, Hand JH, et al. Relevant contact sensitivities in patients with the diagnosis of oral lichen planus. J Am Acad Dermatol 2000;42:177–82. 184. Palestine AG, Nussenblat RB, Chan C-C, et al. Side effects of systemic cyclosporine in patients not undergoing transplantation. Am J Med 1984;77(4):652–6. 185. Silverman S Jr, Bahl S. Oral lichen planus update: clinical characteristics, treatment responses, and malignant transformation. Am J Dent 1997;10:259-63. 186. Cohen DM, Bhattacharyya I, Zunt SL, Tomich CE. Linear IgA disease histopathologically and clinically masquerading as lichen planus. Oral Surg Oral Med Oral Pathol 1999;88(2):196–201. 187. Boisnic S, Frances C, Branchet MC, et al. Immunohistochemical study of oral lesions of lichen planus: diagnostic and pathophysiologic aspects. Oral Surg Oral Med Oral Pathol 1990;70(4):462–5. 188. Laskaris G, Sklavounou A, Angelopoulos A. Direct immunofluorescence in oral lichen planus. Oral Surg Oral Med Oral Pathol 1982;53(5):483–7. 189. Rinaggio J, Neiders ME, Aguirre A, Kumar V. Using immunofluorescence in the diagnosis of chronic ulcerative lesions of the oral mucosa. Compend Contin Educ Dent 1999;20(10):943–50. 190. Andreasen JO. Oral lichen planus. 1. A clinical evaluation of 115 cases. Oral Surg Oral Med Oral Pathol 1968;25(1):31–42. 191. Silverman S Jr, Griffith M. Studies on oral lichen planus II. Follow-up on 200 patients: clinical characteristics and associated malignancy. Oral Surg Oral Med Oral Pathol 1974;37(5):705–10. 192. Silverman S Jr, Gorsky M, Lozada-Nur F. A prospective followup study of 570 patients with oral lichen planus: persistence, remission, and malignant association. Oral Surg Oral Med Oral Pathol 1985;60:30–4. 193. Krutchkoff DK, Cutler L, Laskowski S. Oral lichen planus: the evidence regarding potential malignant transformation. Oral Surg Oral Med Oral Pathol 1978;7(1):1–7. 194. Murti PR, Daftary DK, Bhousi RB, et al. Malignant potential of lichen planus: observations in 722 patients from India. J Oral Pathol 1986;15(2):71–7. 195. van der Meij EH, Schepman KP, Smeele LE, et al. A review of the recent literature regarding malignant transformation
Red and White Lesions of the Oral Mucosa 123 of oral lichen planus. Oral Surg Oral Med Oral Pathol 1999;88(3):307–10. 196. Cohen DM, Bhattacharyya I, Zunt SL, Tomich CE. Linear IgA disease histopathologically and clinically masquerading as lichen planus. Oral Surg Oral Med Pathol 1999;88:196-201. 197. Eisenberg E, Krutchkoff DJ. Lichenoid lesions of oral mucosa. Diagnostic criteria and their importance in the alleged relationship to oral cancer. Oral Surg Oral Med Oral Pathol 1992;73(6):699–704. 198. Hietanen J, Paasonen MR, Kuhlefelt M, Malmstrom M. A retrospective study of oral lichen planus patients with concurrent or subsequent development of malignancy. Oral Oncol 1999;35(3):278–82. 199. Krutchkoff DJ, Eisenberg E. Lichenoid dysplasia: a distinct histopathologic entity. Oral Surg Oral Med Oral Pathol 1985;60(3):308–15. 200. Lovas JGI, Harsanyi BB, El Generdy AK. Oral lichenoid dysplasia: a clinicopathologic analysis. Oral Surg Oral Med Oral Pathol 1989;68(1):57–63. 201. Silverman S Jr, Lozada-Nur F, Migliorati C. Clinical efficacy of prednisone in the treatment of patients with oral inflammatory ulcerative diseases: a study of 55 patients. Oral Surg Oral Med Oral Pathol 1985;59:360–3. 202. Lozada-Nur F, Silverman S Jr. Topically applied fluocinonide in an adhesive base in the treatment of oral vesiculoerosive diseases. Arch Dermatol 1980;116(8):898–901. 203. Lozada-Nur F, Huang MZ. Open preliminary clinical trial of clobetasol proprionate ointment in adhesive paste for treatment of chronic vesiculoerosive disease. Oral Surg Oral Med Oral Pathol 1991;71:283–7. 204. Plemons JM, Rees TD, Zachariah NY. Absorption of a topical steroid and evaluation of adrenal suppression in patients with erosive lichen planus. Oral Surg Oral Med Oral Pathol 1990;69(6):688–93. 205. Giustina TA, Stewart JCB, Ellis CN, et al. Topical application of isotretinoin gel improves oral lichen planus. A double-blind study. Arch Dermatol 1986;122(5):534–6. 206. Camisa C, Allen CM. Treatment of oral erosive lichen planus with systemic isotretinoin. Oral Surg Oral Med Oral Pathol 1986;62(4):393–6. 207. Bollag W, Ott F. Treatment of oral lichen planus with temarotene. Lancet 1989;21;2(8669):974. 208. Eisen D, Ellis CN, Duell EA, et al. Effect of topical cyclosporine rinse on oral lichen planus: a double-blind analysis. N Engl J Med 1990;323(5):290–4. 209. Frances C, Boisnic S, Etiennes C, Szpirglas H. Effect of the local topical application of cyclosporine A on chronic erosive lichen planus of the oral cavity. Dermatologia 1988;177(3):194–5. 210. Balato N, DeRosa S, Bordone F, et al. Dermatological application of cyclosporine A. Arch Dermatol 1989;125(10):1430–1. 211. Koch P, Bahmer FA. Oral lesions and symptoms related to metals used in dental restorations: a clinical, allergological, and histologic study. J Am Acad Dermatol 1999;41(3 Pt 1): 422–30. 212. Finne KAJ, Goransson K, Winckler L. Oral lichen planus and contact allergy to mercury. Int J Oral Surg 1982;11(4):236–9. 213. Eversole LK, Ringer M. The role of dental restorative metal in the pathogenesis of oral lichen planus. Oral Surg Oral Med Oral Pathol 1984;57(4):383–7. 214. Weedon D. The lichenoid tissue reaction. Int J Dermatol 1982;21:203. 215. Brook PM, Day RO. Nonsteroidal anti-inflammatory drugs— differences and similarities. N Engl J Med 1991;324:1716. 216. Firth NA, Reade PD. Angiotensin-converting enzyme inhibitors implicated in oral mucosal lichenoid reactions. Oral Surg Oral Med Oral Pathol 1989;67(1):41–4. 217. Hay KD, Mullen HK, Reade PC. D-penicillamine-induced mucocutaneous lesions with features of pemphigus. Oral Surg Oral Med Oral Pathol 1978;45:385. 218. Mason C, Grisius R, McKean T. Stomatitis medicamentosa associated with gold therapy for rheumatoid arthritis. US Navy Med 1978;69(1):23–5. 219. McCartan BE, McCreary CE. Oral lichenoid drug eruptions. Oral Dis 1997;3(2):58–63. 220. Cohen DM, Bhattacharyya I, Lydiatt WM. Recalcitrant oral ulcers caused by calcium channel blockers: diagnosis and treatment considerations. J Am Dent Assoc 1999; 130(11):1611–8. 221. Potts AJC, Hamburger J, Scully C. The medication of patients with oral lichen planus and the association of nonsteroidal anti-inflammatory drugs with erosive lesions. Oral Surg Oral Med Oral Pathol 1987;64(5):541–3. 222. Robertson WD, Wray D. Ingestion of medication among patients with oral keratoses including lichen planus. Oral Surg Oral Med Oral Pathol 1992;74(2):183–5. 223. Seehafer JR, Rogers RS, Fleming R, et al. Lichen planus-like lesions caused by penicillamine in primary biliary cirrhosis. Arch Dermatol 1981;117(3):140–2. 224. Regezi JA, Sciubba JJ. Oral pathology: clinical pathologic correlations. 3rd ed. Philadelphia: WB Saunders; 1999. p. 99–101,104. 225. Bez C, Lodi G, Sardella A, et al. Oral lichenoid lesions after thalidomide treatment. Dermatology 1999;199(2):195. 226. Woo SB, Lee SJ, Schubert MM. Graft-vs.-host disease. Crit Rev Oral Biol Med 1997;8(2):201–16. 227. Sale GE, Shulman HM, Schubert MM, et al. Oral and ophthalmic pathology of graft versus host disease in man: predictive value of the lip biopsy. Hum Pathol 1981; 12(11):1022–30. 228. Peck GL, Herzig GP, Elias PM. Toxic epidermal necrolysis in a patient with graft-vs-host reaction. Arch Dermatol 1972;105(4):561–9. 229. Schubert MM, Sullivan KR, Truelove EL. Head and neck complications of bone marrow transplantation. In: Petersen DE, Elias EG, Sonis ST, editors. Head and neck management of the cancer patient. Boston: Martinus Nijhoff; 1986. p. 401. 230. Nakamura S, Hiroki A, Shinohara M, et al. Oral involvement in chronic graft-versus-host disease after allogeneic bone marrow transplantation. Oral Surg Oral Med Oral Pathol 1996;82(5):556–63. 231. Schubert MM, Sullivan KM. Recognition, incidence, and management of oral graft-versus-host disease. NCI Monogr 1990;9:135–43. 232. Rodu B, Gockerman JP. Oral manifestations of the chronic graft-vs-host reaction. JAMA 1983;249(4):504–7. 233. Nagler R, Marmary Y, Krausz Y, et al. Major salivary gland dysfunction in human acute and chronic graft-versus-host disease (GVHD). Bone Marrow Transplant 1996;17(2):219–24. 234. Kanda Y, Arai C, Chizuka A, et al. Pyogenic granuloma of the tongue early after allogeneic bone marrow transplantation for multiple myeloma. Leuk Lymphoma 2000;37(3–4):445–9. 235. Lee L, Miller PA, Maxymiw WG, et al. Intraoral pyogenic granuloma after allogeneic bone marrow transplant. Report of three cases. Oral Surg Oral Med Oral Pathol 1994;78(5):607–10.
Page 1 and 2: 5 ▼ RED AND WHITE LESIONS OF THE
Page 3 and 4: Red and White Lesions of the Oral M
Page 37: Red and White Lesions of the Oral M
Page 41: Red and White Lesions of the Oral M

Ch05: Red and White Lesions of the Oral Mucosa

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?